C9orf100, a new member of the Dbl-family guanine nucleotide exchange factors, promotes cell proliferation and migration in hepatocellular carcinoma

被引:17
作者
Wang, Haixiao [1 ]
Li, Yandong [2 ,3 ]
Wang, Yuping [2 ,3 ,4 ]
Han, Ze-Guang [2 ,3 ]
Cai, Bing [1 ]
机构
[1] Nanjing Med Univ, Dept Hepatobiliary Surg, Wuxi Peoples Hosp, Wuxi 214023, Jiangsu, Peoples R China
[2] Shanghai Jiao Tong Univ, Chinese Natl Human Genome Ctr, Rui Jin Hosp, Sch Med, Shanghai 200030, Peoples R China
[3] Chinese Natl Human Genome Ctr, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai 201203, Peoples R China
[4] Lanzhou Univ, Dept Med Biochem & Mol Biol, Sch Basic Med Sci, Lanzhou 730000, Gansu, Peoples R China
关键词
hepatocellular carcinoma; C9orf100; guanine nucleotide exchange factors; cell proliferation; cell migration; RHO-GTPASES; ONCOGENE PRODUCT; MEMBRANE; BIOLOGY; DOMAIN; PH;
D O I
10.3892/mmr.2012.783
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dbl-family guanine nucleotide exchange factors (GEFs) are important activators of Rho GTPases, which are significantly associated with tumorigenesis and metastasis. The catalytic ability of the Dbl-family GEFs to activate Rho GTPases depends on their Dbl-homology domain followed by a pleckstrin-homology domain. In the present study, we showed that C9orf100, a new member of the Dbl-family GEFs with a minimal catalytic unit, may contribute to hepatocellular carcinoma (HCC). Quantitative real-time PCR results demonstrated that C9orf100 was highly and widely upregulated in 42/44 (95.5%, >2-fold) HCC specimens compared with adjacent non-cancerous livers, and this upregulation was correlated with intrahepatic metastasis and alpha-fetoprotein levels of HCC. Furthermore, the ectopic expression of C9orf100 promoted cell proliferation and colony formation in Huh-7 and YY-8103 cells, whereas silencing of C9orf100 resulted in the suppression of cell growth in MHCC-97H and PLC/PRF/5 cells. Flow cytometry confirmed this effect on MHCC-97H cell growth and indicated that C9orf100 may function in the G(2)/M phase. In addition, we showed that C9orf100 is involved in the positive regulation of HCC cell migration by a transwell chamber analysis. Our findings suggest that C9orf100 plays a potential oncogenic role in the development and metastasis of HCC.
引用
收藏
页码:1169 / 1174
页数:6
相关论文
共 23 条
[1]   The Dbs PH domain contributes independently to membrane targeting and regulation of guanine nucleotide-exchange activity [J].
Baumeister, Mark A. ;
Rossman, Kent L. ;
Sondek, John ;
Lemmon, Mark A. .
BIOCHEMICAL JOURNAL, 2006, 400 (563-572) :563-572
[2]   New aspects of diagnosis and therapy of hepatocellular carcinoma [J].
Bruix, J ;
Hessheimer, AJ ;
Forner, A ;
Boix, L ;
Vilana, R ;
Llovet, JM .
ONCOGENE, 2006, 25 (27) :3848-3856
[3]   Membrane and juxtamembrane targeting by PH and PTB domains [J].
DiNitto, Jonathan P. ;
Lambright, David G. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2006, 1761 (08) :850-867
[4]   Rho GTPases in cell biology [J].
Etienne-Manneville, S ;
Hall, A .
NATURE, 2002, 420 (6916) :629-635
[5]   THE PREDICTED DBL-ONCOGENE PRODUCT DEFINES A DISTINCT CLASS OF TRANSFORMING PROTEINS [J].
EVA, A ;
VECCHIO, G ;
RAO, CD ;
TRONICK, SR ;
AARONSON, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (07) :2061-2065
[6]  
HART MJ, 1994, J BIOL CHEM, V269, P62
[7]   Up-regulation of DLK1 as an imprinted gene could contribute to human hepatocellular carcinoma [J].
Huang, Jian ;
Zhang, Xin ;
Zhang, Min ;
Zhu, Jing-De ;
Zhang, Yun-Li ;
Lin, Yun ;
Wang, Ke-Sheng ;
Qi, Xiao-Fei ;
Zhang, Qin ;
Liu, Guang-Zhen ;
Yu, Jian ;
Cui, Ying ;
Yang, Peng-Yuan ;
Wang, Zhi-Qin ;
Han, Ze-Guang .
CARCINOGENESIS, 2007, 28 (05) :1094-1103
[8]   Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling [J].
Huang, Jian ;
Zheng, Da-Li ;
Qin, Feng-Song ;
Cheng, Na ;
Chen, Hui ;
Wan, Bing-Bing ;
Wang, Yu-Ping ;
Xiao, Hua-Sheng ;
Han, Ze-Guang .
JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (01) :223-241
[9]  
Iizuka N, 2002, CANCER RES, V62, P3939
[10]   Hepatocellular carcinoma [J].
Llovet, JM ;
Burroughs, A ;
Bruix, J .
LANCET, 2003, 362 (9399) :1907-1917